PRESS RELEASE published on 10/17/2024 at 07:02, 1 year 11 months ago Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024 Sartorius Stedim Biotech posts unaudited 9-month results for 2024, confirming outlook. Sales revenue 2,029 million euros, EBITDA 565 million euros, strong consumables demand EBITDA Sartorius Stedim Biotech Sales Revenue 9-month Figures Consumables
BRIEF published on 10/01/2024 at 11:19, 1 year 11 months ago Statement on the number of shares and voting rights at Sartorius Stedim Biotech Share Capital Voting Rights Actions Sartorius Stedim Biotech Regulatory
PRESS RELEASE published on 10/01/2024 at 11:15, 1 year 11 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Press release regarding the declaration of the number of shares and voting rights of Sartorius Stedim Biotech S.A. in France Voting Rights Capital Shares Sartorius Stedim Biotech France
PRESS RELEASE published on 10/01/2024 at 11:14, 1 year 11 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares number of shares and voting rights making up the issued capital. Details according to French regulations Voting Rights Shares French Regulations Sartorius Stedim Biotech Issued Capital
BRIEF published on 09/03/2024 at 10:20, 2 years ago Sartorius Stedim Biotech SA Announces Number of Shares and Voting Rights Voting Rights Shares Issued Capital Regulatory News Sartorius Stedim
PRESS RELEASE published on 09/03/2024 at 10:15, 2 years ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Press release regarding the declaration of the number of shares and voting rights at Sartorius Stedim Biotech S.A. in France Voting Rights Déclaration Shares Sartorius Stedim Biotech France
PRESS RELEASE published on 09/03/2024 at 10:15, 2 years ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in the issued capital. Total shares: 97,330,405. Total voting rights: 165,568,221 Voting Rights Shares Sartorius Stedim Biotech Issued Capital Announcement
BRIEF published on 08/02/2024 at 12:27, 2 years 1 month ago Sartorius Stedim Biotech Announces Share and Voting Rights Update Voting Rights Shares Regulatory Compliance Sartorius Stedim Biotech Issued Capital
PRESS RELEASE published on 08/02/2024 at 12:23, 2 years 1 month ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the total number of shares and voting rights, as of July 31, 2024, in compliance with legal requirements Voting Rights Déclaration Shares Sartorius Stedim Biotech SA July 31 2024
PRESS RELEASE published on 08/02/2024 at 12:22, 2 years 1 month ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in their issued capital. Details in the announcement Voting Rights Shares AMF Sartorius Stedim Biotech SA French Regulatory News
Published on 09/17/2026 at 13:30, 15 minutes ago UniDoc Health Equips San Juan, Puerto Rico Ambulances With Live Patient Video
Published on 09/17/2026 at 13:30, 15 minutes ago Electric Royalties Reports Permitting Progress and New Exploration Results Across Critical Metals Royalty Portfolio
Published on 09/17/2026 at 13:00, 45 minutes ago Organto Foods Strengthens Scalable European Operating Platform and Launches AI Powered Operational Transformation
Published on 09/17/2026 at 13:00, 45 minutes ago Gold Terra Announces Fall Drilling with Three (3) Rigs Active on the Con Mine, Yellowknife, NWT
Published on 09/17/2026 at 13:00, 45 minutes ago NiobiumX Mining Inc. Appoints Athabasca Basin Discovery Geologist Erik Sehn to Board of Directors
Published on 09/17/2026 at 13:25, 19 minutes ago Custodian Property Income REIT plc: Results of Annual General Meeting
Published on 09/17/2026 at 13:25, 20 minutes ago CDTL Highlights E-Drive + EMB Technologies for Commercial Vehicles at IAA Transportation 2026
Published on 09/17/2026 at 13:25, 20 minutes ago ATOME PLC: Notice of Dispute and Intent to Submit Claim to Arbitration under the UK - Paraguay Bilateral Investment Treaty ("the Treaty" or "BIT")
Published on 09/17/2026 at 13:05, 40 minutes ago Aurzen Expands Its Presence in Germany with Launch on Joybuy, Bringing EAZZE D1 and ZIP to More Consumers
Published on 09/16/2026 at 17:45, 20 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 6 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 19 hours ago Report on the Combined General Meeting of the 10th of September 2026
